ANAPLASTIC LARGE CELL LYMPHOMA, ALK-POSITIVE
Clinical trials for ANAPLASTIC LARGE CELL LYMPHOMA, ALK-POSITIVE explained in plain language.
Never miss a new study
Get alerted when new ANAPLASTIC LARGE CELL LYMPHOMA, ALK-POSITIVE trials appear
Sign up with your email to follow new studies for ANAPLASTIC LARGE CELL LYMPHOMA, ALK-POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to beat rare childhood lymphoma
Disease control Recruiting nowThis study tests a new treatment for children, teens, and young adults with a rare type of blood cancer (ALK+ anaplastic large cell lymphoma) that has come back or not responded to standard therapy. The approach combines an immunotherapy drug (nivolumab) with chemotherapy, follow…
Matched conditions: ANAPLASTIC LARGE CELL LYMPHOMA, ALK-POSITIVE
Phase: PHASE2 • Sponsor: New York Medical College • Aim: Disease control
Last updated May 26, 2026 04:47 UTC
-
Supercharged donor cells take on stubborn lymphomas
Disease control Recruiting nowThis early-stage study tests a new approach for people with certain lymphomas (like Hodgkin lymphoma) that have come back or not responded to standard treatments. Researchers take immune cells from healthy donors, add a special receptor (C7R) to help them survive longer, and targ…
Matched conditions: ANAPLASTIC LARGE CELL LYMPHOMA, ALK-POSITIVE
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 26, 2026 04:34 UTC
-
New hope for kids with rare ALK-driven cancers: targeted pill shows promise
Disease control Recruiting nowThis study tests a drug called brigatinib in children and young adults (ages 1 to 25) with certain cancers that have an ALK gene change. The goal is to find the best dose and see if the drug is safe and works against these tumors. About 65 participants will take brigatinib pills,…
Matched conditions: ANAPLASTIC LARGE CELL LYMPHOMA, ALK-POSITIVE
Phase: PHASE1, PHASE2 • Sponsor: Princess Maxima Center for Pediatric Oncology • Aim: Disease control
Last updated May 18, 2026 12:02 UTC
-
Massive T-Cell lymphoma database aims to unlock better treatments
Knowledge-focused Recruiting nowThis study is creating a large database of information from 1,000 people with T-cell lymphoma. Researchers will collect medical records and tumor samples to learn more about the disease and how to improve care. No new treatments are being tested; the goal is to gather data for fu…
Matched conditions: ANAPLASTIC LARGE CELL LYMPHOMA, ALK-POSITIVE
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated May 22, 2026 13:52 UTC